241 related articles for article (PubMed ID: 1597726)
1. A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors.
Bomanji J; Mather S; Moyes J; Ellison D; Grossman A; Britton KE; Besser GM
J Nucl Med; 1992 Jun; 33(6):1121-4. PubMed ID: 1597726
[TBL] [Abstract][Full Text] [Related]
2. Comparison of labeled MIBG and somatostatin analogs in imaging neuroendocrine tumors.
Lastoria S; Maurea S; Vergara E; Acampa W; Varrella P; Klain M; Muto P; Bernardy JD; Salvatore M
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):145-9. PubMed ID: 9002775
[TBL] [Abstract][Full Text] [Related]
3. Imaging of carcinoid tumors with iodine-123 metaiodobenzylguanidine.
Bomanji J; Levison DA; Zuzarte J; Britton KE
J Nucl Med; 1987 Dec; 28(12):1907-10. PubMed ID: 3681447
[TBL] [Abstract][Full Text] [Related]
4. [111IN-octreotide and 123I-MIBG scintigraphy in the diagnosis of small intestinal carcinoid tumors--results of a comparative investigation].
Dresel S; Tatsch K; Zachoval R; Hahn K
Nuklearmedizin; 1996 Apr; 35(2):53-8. PubMed ID: 8721576
[TBL] [Abstract][Full Text] [Related]
5. Comparison of somatostatin analogue and metaiodobenzylguanidine scintigraphy for the detection of carcinoid tumours.
Nocaudie-Calzada M; Huglo D; Carnaille B; Proye C; Marchandise X
Eur J Nucl Med; 1996 Nov; 23(11):1448-54. PubMed ID: 8854840
[TBL] [Abstract][Full Text] [Related]
6. Successful and unsuccessful approaches to imaging carcinoids: comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue.
Macfarlane D; Gonin J; Wieland D; Mangner T; Froelich J; Beierwaltes W; Shapiro B
Eur J Nucl Med; 1996 Feb; 23(2):131-40. PubMed ID: 8925846
[TBL] [Abstract][Full Text] [Related]
7. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
Kaltsas G; Korbonits M; Heintz E; Mukherjee JJ; Jenkins PJ; Chew SL; Reznek R; Monson JP; Besser GM; Foley R; Britton KE; Grossman AB
J Clin Endocrinol Metab; 2001 Feb; 86(2):895-902. PubMed ID: 11158063
[TBL] [Abstract][Full Text] [Related]
8. Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma.
Tenenbaum F; Lumbroso J; Schlumberger M; Mure A; Plouin PF; Caillou B; Parmentier C
J Nucl Med; 1995 Jan; 36(1):1-6. PubMed ID: 7799058
[TBL] [Abstract][Full Text] [Related]
9. Iodine-123-Tyr-3-octreotide uptake in pancreatic endocrine tumors and in carcinoids in relation to hormonal inhibition by octreotide.
Nocaudie-Calzada M; Huglo D; Deveaux M; Carnaille B; Proye C; Marchandise X
J Nucl Med; 1994 Jan; 35(1):57-62. PubMed ID: 8271061
[TBL] [Abstract][Full Text] [Related]
10. I-123 MIBG imaging of metastatic carcinoid tumor from the rectum.
Watanabe N; Seto H; Ishiki M; Shimizu M; Kageyama M; Wu YW; Nagayoshi T; Kamisaki Y; Kakishita M
Clin Nucl Med; 1995 Apr; 20(4):357-60. PubMed ID: 7788995
[TBL] [Abstract][Full Text] [Related]
11. Iodine-131 metaiodobenzylguanidine scintigraphy of carcinoid tumors.
Feldman JM; Blinder RA; Lucas KJ; Coleman RE
J Nucl Med; 1986 Nov; 27(11):1691-6. PubMed ID: 3772504
[TBL] [Abstract][Full Text] [Related]
12. L-3-[123I]Iodo-alpha-methyltyrosine scintigraphy in carcinoid tumors: correlation with biochemical activity and comparison with [111In-DTPA-D-Phe1]-octreotide imaging.
Jager PL; Meijer WG; Kema IP; Willemse PH; Piers DA; de Vries EG
J Nucl Med; 2000 Nov; 41(11):1793-800. PubMed ID: 11079485
[TBL] [Abstract][Full Text] [Related]
13. Carcinoid tumors: iodine-131 MIBG scintigraphy.
Hanson MW; Feldman JM; Blinder RA; Moore JO; Coleman RE
Radiology; 1989 Sep; 172(3):699-703. PubMed ID: 2772175
[TBL] [Abstract][Full Text] [Related]
14. [Role of 131I-metaiodobenzylguanidine scintigraphy in the diagnosis of intestinal carcinoids].
Bihl H; Sautter-Bihl ML; Wilhelm KR; Kimmig B
Nuklearmedizin; 1987 Dec; 26(6):263-7. PubMed ID: 3438170
[TBL] [Abstract][Full Text] [Related]
15. Scintiscans and carcinoid tumors.
Carnaille B; Nocaudie M; Pattou F; Huglo D; Deveaux M; Marchandise X; Proye C
Surgery; 1994 Dec; 116(6):1118-21; discussion 1121-2. PubMed ID: 7985096
[TBL] [Abstract][Full Text] [Related]
16. Radiolabeled somatostatin analog scintigraphy in medullary thyroid carcinoma and carcinoid tumor.
Rufini V; Salvatori M; Saletnich I; Valenza V; Maussier ML; Martino G; Corsello SM; Pantusa M; Casolo A; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):140-4. PubMed ID: 9002774
[TBL] [Abstract][Full Text] [Related]
17. Iodine-131-metaiodobenzylguanidine uptake in metastatic carcinoid tumor to the orbit.
Hanson MW; Schneider AM; Enterline DS; Feldman JM; Gockerman JP
J Nucl Med; 1998 Apr; 39(4):647-50. PubMed ID: 9544672
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of Somatostatin Receptor Scintigraphy (Tc-[HYNIC, Tyr3]-Octreotide) and 123I-Metaiodobenzylguanidine Scintigraphy in Patients with SDHx Gene-Related Pheochromocytomas and Paragangliomas Detected by Computed Tomography.
Michałowska I; Ćwikła JB; Pęczkowska M; Furmanek MI; Buscombe JR; Michalski W; Prejbisz A; Szperl M; Malinoc A; Moczulski D; Szutkowski Z; Kawecki A; Antoniewicz J; Pęczkowski P; Lewczuk A; Otto M; Cichocki A; Bednarek-Tupikowska G; Kabat M; Janaszek-Sitkowska H; Przybyłowska K; Janas J; Neumann HP; Januszewicz A
Neuroendocrinology; 2015; 101(4):321-30. PubMed ID: 25791839
[TBL] [Abstract][Full Text] [Related]
19. Ten years of experience with MIBG applications and the potential of new radiolabeled peptides: a personal overview and concluding remarks.
Shapiro B
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):150-5. PubMed ID: 9002776
[TBL] [Abstract][Full Text] [Related]
20. 111In-pentetreotide and 123I-MIBG for detection and resection of lymph node metastases of a carcinoid not visualized by CT, MRI or FDG-PET.
Yüksel M; Eziddin S; Ladwein E; Haas S; Biersack HJ
Ann Nucl Med; 2005 Oct; 19(7):611-5. PubMed ID: 16363628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]